Daniel Rabinowitz - 08 Jan 2025 Form 4 Insider Report for Natera, Inc. (NTRA)

Reporting relationship: SEC. AND CHIEF LEGAL OFFICER
Issuer ticker: NTRA
Reported as of: 08 Jan 2025
Net transaction value: -$1,090,901
SEC form: 4
Accepted by SEC: 10 Jan 2025, 21:35:04 UTC
Prior SEC filing: 30 Oct 2024
Next SEC filing: 21 Jan 2025
Source filing: View source filing
Reporting owner signature: /s/ Tami Chen, Attorney-in-Fact

Key filing fact

Daniel Rabinowitz filed Form 4 for Natera, Inc. (NTRA) on 10 Jan 2025.

Key facts

This page summarizes Daniel Rabinowitz's Form 4 filing for Natera, Inc. (NTRA).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 10 Jan 2025, 21:35.

Change

Previous filing in this sequence was filed on 30 Oct 2024.
Current net transaction value: -$1,090,901.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

NTRA transaction

Common Stock

Sale

Transaction value: $1,090,901
Shares: -6,223
Change %: -3%
Price: $175.30
Shares after: 199,804
Date: 08 Jan 2025
Ownership: Direct
Footnotes: F1, F2

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Rule 10b5-1 trading plan

These transactions were reported as open-market trades under a Rule 10b5-1 plan. The plan lets an insider set trading instructions in advance, which can reduce the risk of trading while in possession of material nonpublic information.

Original filing language: transaction made pursuant to a contract, instruction, or written plan intended to satisfy Rule 10b5-1(c).

Explanation of responses 2 footnotes

Footnote F1

The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 14, 2024.

Footnote F2

The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $175.00 to $175.49 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.